217
Participants
Start Date
September 1, 2021
Primary Completion Date
June 11, 2025
Study Completion Date
December 31, 2027
Taletrectinib
400mg or 600mg QD
Centre d'Essais Précoces de Cancerologie de Marseille, Marseille
Renovatio Clinical, El Paso
Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milan
Ospedale San Raffaele, Milan
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
IEO Istituto Europeo di Oncologia, Milan
Hospital Universitario Ramon y Cajal, Madrid
Hospital Universitario Clinico San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
Hospital Regional Universitario de Malaga, Málaga
Memorial Cancer Institute at Memorial Hospital East, Hollywood
Memorial Cancer Institute at Memorial Hospital West, Pembroke Pines
SCRI - Florida Cancer Specialists South, Fort Myers
CHU Rennes - Hospital Pontchaillou, Rennes
SCRI - Tennessee Oncology, Nashville
CHU Grenoble Alpes- Hospital Michallon, La Tronche
Hospital Universitario Virgen Macarena, Seville
Cleveland Clinic Foundation, Cleveland
Institut De Cancérologie De L'ouest, Saint-Herblain
Institut Gustave Roussy, Saint-Herblain
Instituto Valenciano de Oncologia IVO, Valencia
Hospital Clinico Universitario de Valencia, Valencia
Pusan National University Hospital, Busan
Institut Jean Godinot, Reims
Mayo Clinic, Rochester
Chonnam National University Hwasun Hospital, Hwasun
Centre Léon Bérard, Lyon 08
Istituto Tumori Giovanni Paolo II IRCCS Ospedale Oncologico, Bari
SCRI - Hematology Oncology Clinic, Baton Rouge
APHP- Hôpital Europeen Georges Pompidou (HEGP), Paris
Texas Oncology, P.A., Dallas
MD Anderson Cancer Center, Houston
Renovatio Clinical, The Woodlands
Azienda Ospedaliera Universitaria- Università degli Studi della Campania, Napoli
CHU de Poitiers Pole regional, Poitiers
Keck Medicine of University of Southern California, Los Angeles
Beverly Hills Cancer Center, Beverly Hills
The Oncology Institute of Hope and Innovation, Glendale
Moores Cancer Center at UC San Diego, La Jolla
UCI Medical Center, Orange
Cancer Specialists of North Florida, Jacksonville
Ventura County Hematology-Oncology Specialists, Oxnard
Humanitas Istituto Clinico Catanese, Misterbinanoco, Catania
Northwest Medical Specialties, PLLC, Tacoma
Beijing Cancer Hospital, Beijing
Shanghai Pulmonary Hospital, Shanghai
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Pusan National University Yangsan Hospital, Gyeongsang
Center for Cancer Research, Brick
Princess Margaret Cancer Centre, Toronto
McGill University Health Centre Research Institute, Montreal
Hunan Cancer Hospital, Changsha
West China Hospital, Chengdu
Shandong Cancer Hospital, Jinan
Wuhan Union Hospital, Wuhan
Henan Cancer Hospital, Zhengzhou
CHU Lyon - Hôpital Cardio-Vasculaire et Pneumologique Louis Pradel, Bron
Instytut Centrum Zdrowia Matki Polki, Lodz
AOU Cagliari- P.O. Policlinico Universitario Duilio Casula, Monserrato
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma
National Hospital Organization Kyushu Cancer Center, Fukuoka
National Cancer Center Hospital East, Kashiwa
National Cancer Center Hospital, Tokyo
Sendai Kousei Hospital, Miyagi
Aichi Cancer Center Hospital, Nagoya
Kindai University Hospital, Osaka
Shizuoka Cancer Center, Shizuoka
The Cancer Institute Hospital of JFCR, Tokyo
Med-Polonia Sp. z o.o., Poznan
MICS Centrum Medyczne Toruńa, Torun
Asan Medical Center, Seoul
Korea University Guro Hospital, Seoul
Clinica Mi Tres Torres, Barcelona
Hospital Quironsalud Barcelona, Barcelona
Hospital Universitari Vall d'Hebron, Barcelona
ICO l'Hospitalet - Hospital Duran i Reynals L'Hospitalet de Llobregat, Barcelona
Lead Sponsor
Nuvation Bio Inc.
INDUSTRY